Locations
San Diego, CA, USA · North America
industry
Health · Biotechnology · DeepTech
Size
201-1000 employees
Stage
Other
founded in
1996
Since 1996 TriLink has offered cutting edge services to researchers in the fields of gene therapy, nucleoside chemotherapy, oligonucleotide therapy and diagnostics. We specialize in the manufacture of modified nucleic acid products including custom oligonucleotides, mRNA, modified nucleoside triphosphates, CleanAmp PCR Products, phosphoramidites and other small molecules. TriLink's founders have been at the forefront of the advancements in oligonucleotide and mRNA synthesis. Our scientists and technicians have decades of collective experience in synthesizing nucleic acid products for research, diagnostics and therapeutic applications.
Something looks off?